ProQR Therapeutics N.V. buy Citigroup Inc.
Start price
19.04.24
/
50%
€1.78
Target price
19.04.25
€1.88
Performance (%)
6.29%
Price
23.04.24
€1.89
Summary
This prediction is currently active. With a performance of 6.29%, the BUY prediction by Citigroup_Inc_ for ProQR Therapeutics N.V. is trending in the right direction. This prediction currently runs until 19.04.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| ProQR Therapeutics N.V. | - |
| iShares Core DAX® | -0.992% |
| iShares Nasdaq 100 | -0.225% |
| iShares Nikkei 225® | -0.736% |
| iShares S&P 500 | -0.509% |
Comments by Citigroup_Inc_ for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its price target raised by analysts at Citigroup Inc. from $1.80 to $2.00. They now have a "buy" rating on the stock.
Ratings data for PRQR provided by MarketBeat